Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/21259
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Houghton-Gisby, J | - |
dc.contributor.author | Harvey, AJ | - |
dc.date.accessioned | 2020-07-22T11:05:43Z | - |
dc.date.available | 2020-06-18 | - |
dc.date.available | 2020-07-22T11:05:43Z | - |
dc.date.issued | 2020-06-18 | - |
dc.identifier.citation | Houghton-Gisby, J. and Harvey, A.J. (2020) 'ACBD3, Its Cellular Interactors, and Its Role in Breast Cancer', Cancer Studies and Therapeutics, 2020, 5 (2), pp. 1 - 7. doi:10.31038/CST.2020523. | en_US |
dc.identifier.issn | 2002-7184 | - |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/21259 | - |
dc.description.abstract | ACBD3 breast cancer research to date reveals that overexpression at mRNA and protein level is near universal in breast tumour tissue and that high ACBD3 expression is associated with worse patient prognosis. ACBD3 has been shown to have an important role in specifying cell fate and maintaining stem cell pools in neurological development and deletion of ACBD3 in human cell lines prevents cell division. Combined with observations that β-catenin expression and activity is increased when ACBD3 is overexpressed it has been hypothesised that ACBD3 promotes breast cancer by increasing Wnt signalling. This may only be one aspect of ACBD3’s effects as its expression and localisation regulates steroidogenesis, calcium mediated redox stress and inflammation, glucose import and PI(4)P production which are all intrinsically linked to breast cancer dynamics. Given the wide scope for a role of ACBD3 in breast cancer, we explore its interactors and the implications of preventing these interactions. | en_US |
dc.format.extent | 1 - 7 | - |
dc.language.iso | en | en_US |
dc.publisher | Research Open World | en_US |
dc.subject | ACBD3 | en_US |
dc.subject | breast cancer | en_US |
dc.subject | Chromosome 1 | en_US |
dc.subject | golgi | en_US |
dc.subject | NUMB | en_US |
dc.subject | PI4Kβ | - |
dc.subject | phosphatidylinositol | - |
dc.subject | protein kinase A | - |
dc.subject | steroidogenesis | - |
dc.subject | Wnt signalling | - |
dc.title | ACBD3, Its Cellular Interactors, and Its Role in Breast Cancer | en_US |
dc.type | Article | en_US |
dc.identifier.doi | https://doi.org/10.31038/CST.2020523 | - |
dc.relation.isPartOf | Cancer Studies and Therapeutics | - |
pubs.issue | 2 | - |
pubs.publication-status | Published | - |
pubs.volume | 5 | - |
dc.identifier.eissn | 2002-7184 | - |
dc.identifier.eissn | 2002-7184 | - |
Appears in Collections: | Dept of Health Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 1.93 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.